NEJM Jul 1
http://www.nejm.org/doi/full/10.1056/NEJMoa1302507?query=featured_home
"CONCLUSIONS
A fixed-dose regimen of apixaban alone was noninferior to conventional therapy for the treatment of acute venous thromboembolism and was associated with significantly less bleeding"
No comments:
Post a Comment